2021, Number 4
<< Back Next >>
Acta Med 2021; 19 (4)
Recurrent Guillain-Barré syndrome associated with SARS-CoV-2 infection
Domínguez CLG, Alcocer MJL, Domínguez GLG, Arellano AJG
Language: Spanish
References: 22
Page: 554-557
PDF size: 140.86 Kb.
ABSTRACT
Introduction: Guillain-Barré syndrome (GBS) is generally considered monophasic, but recurrences occur in a subgroup of patients with a recurrence rate of 1 to 6%. With the advent of the SARS-CoV-2 pandemic, reports of GBS have increased, in addition to recurrent GBS.
Clinical case: 46-year-old male, who six years ago presented GBS associated with Campylobacter jejuni, with ad integrum recovery; in the last year he presented a GBS recurrence, but with a difference of being more severe and with a descending character, unlike from the first episode. On both occasions, he was treated by the same medical team, managed in a similar way, achieving a later recovery in the second episode.
Conclusions: Although there is still controversy in the literature, recurrent GBS occurs in younger people, and the pictures can be more severe in subsequent episodes.
REFERENCES
Andary MT, Oleszek JL, Maurelus K, White-McCrimmon RY, Klein MJ. Guillain-Barre syndrome. Medscape. 2020. Available in: http://emedicine.medscape.com/article/315632-overview#a0156
Gunatilake SS, Gamlath R, Wimalaratna H. An unusual case of recurrent Guillain-Barré syndrome with normal cerebrospinal fluid protein levels: a case report. BMC Neurol. 2016; 16 (1): 161. doi: 10.1186/s12883-016-0687-z.
Kuitwaard K, van Koningsveld R, Ruts L, Jacobs BC, van Doorn PA. Recurrent Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry. 2009; 80 (1): 56-59. doi: 10.1136/jnnp.2008.156463.
Fokke C, van den Berg B, Drenthen J, Walgaard C, van Doorn PA, Jacobs BC. Diagnosis of Guillain-Barré syndrome and validation of Brighton criteria. Brain. 2014; 137 (Pt 1): 33-43.
Mossberg N, Nordin M, Movitz C, Nilsson S, Hellstrand K, Bergstrom T et al. The recurrent Guillain-Barré syndrome: a long-term population-based study. Acta Neurol Scand. 2012; 126 (3): 154-161. doi: 10.1111/j.1600-0404.2012.01667.x.
McDonnell EP, Altomare NJ, Parekh YH, Gowda RC, Parikh PD, Lazar MH et al. COVID-19 as a trigger of recurrent Guillain-Barré syndrome. Pathogens. 2020; 9 (11): 965. doi: 10.3390/pathogens9110965.
Virani A, Rabold E, Hanson T, Haag A, Elrufay R, Cheema T et al. Guillain-Barré Syndrome associated with SARS-CoV-2 infection. IDCases. 2020; 20: e00771.
Abu-Rumeileh S, Garibashvili T, Ruf W, Fangerau T, Kassubek J, Althaus K et al. Exacerbation of chronic inflammatory demyelinating polyneuropathy in concomitance with COVID-19. J Neurol Sci. 2020; 418: 117106.
Chao CC, Tsai LK, Chiou YH, Tseng MT, Hsieh ST, Chang SC et al. Peripheral nerve disease in SARS: report of a case. Neurology. 2003; 61 (12): 1820-1821.
Stainsby B, Howitt S, Porr J. Neuromusculoskeletal disorders following SARS: a case series. J Can Chiropr Assoc. 2011; 55 (1): 32-39.
Mao L, Wang M, Chen S, He Q, Chang J, Hong C et al. Neurological manifestations of hospitalized patients with COVID-19 in Wuhan, China: a retrospective case series study. MedRxiv. 2020. doi: 10.1101/2020.02.22.20026500.
Zhao H, Shen D, Zhou H, Liu J, Chen S. Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence? Lancet Neurol. 2020; 19 (5): 383-384.
Toscano G, Palmerini F, Ravaglia S, Ruiz L, Invernizzi P, Cuzzoni MG et al. Guillain-Barré syndrome associated with SARS-CoV-2. N Engl J Med. 2020; 382 (26): 2574-2576. doi: 10.1056/NEJMc2009191.
Mao L, Jin H, Wang M, Hu Y, Chen S, He Q et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020; 77 (6): 683-690.
Baxter R, Lewis N, Bakshi N, Vellozzi C, Klein NP; CISA Network. Recurrent Guillain-Barre syndrome following vaccination. Clin Infect Dis. 2012; 54 (6): 800-804. doi: 10.1093/cid/cir960.
Taly AB, Gupta SK, Anisya V, Shankar SK, Rao S, Das KB et al. Recurrent Guillain Barre' syndrome: a clinical, electrophysiological and morphological study. J Assoc Physicians India. 1995; 43 (4): 249-252.
Grand'Maison F, Feasby TE, Hahn AF, Koopman WJ. Recurrent Guillain-Barré syndrome. Clinical and laboratory features. Brain. 1992; 115 (Pt 4): 1093-1106. doi: 10.1093/brain/115.4.1093.
Das A, Kalita J, Misra UK. Recurrent Guillain Barre' syndrome. Electromyogr Clin Neurophysiol. 2004; 44 (2): 95-102.
Trujillo Gittermann LM, Valenzuela Feris SN, von Oetinger Giacoman A. Relación entre COVID-19 y síndrome de Guillain-Barré en adultos. revisión sistemática. Neurología. 2020; 35 (9): 646-654. doi: 10.1016/j.nrl.2020.07.004.
Serrano-Serrano B, López-Hernández N, Dahl-Cruz F, Elvira-Soler E, Díaz-Marín C. Encefalitis multifocal como manifestación neurológica de la infección por COVID-19. Rev Neurol. 2020; 71: 351-352. doi: 10.33588/rn.7109.2020226.
Esteban Molina A, Mata Martínez M, Sánchez Chueca P, Carrillo López A, Sancho Val I, Sanjuan-Villarreal TA. Síndrome de Guillain-Barré asociado a infección por COVID-19. Med Intensiva. 2020; 44 (8): 513-514. doi: 10.1016/j.medin.2020.04.015.
Dyck PJB, Tracy JA. History, diagnosis, and management of chronic inflammatory demyelinating polyradiculoneuropathy. Mayo Clin Proc. 2018; 93 (6): 777-793.